1. Home
  2. INUV vs SAVA Comparison

INUV vs SAVA Comparison

Compare INUV & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INUV
  • SAVA
  • Stock Information
  • Founded
  • INUV N/A
  • SAVA 1998
  • Country
  • INUV United States
  • SAVA United States
  • Employees
  • INUV N/A
  • SAVA N/A
  • Industry
  • INUV Advertising
  • SAVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • INUV Consumer Discretionary
  • SAVA Health Care
  • Exchange
  • INUV Nasdaq
  • SAVA Nasdaq
  • Market Cap
  • INUV 62.8M
  • SAVA 70.5M
  • IPO Year
  • INUV N/A
  • SAVA N/A
  • Fundamental
  • Price
  • INUV $3.48
  • SAVA $2.01
  • Analyst Decision
  • INUV Strong Buy
  • SAVA Buy
  • Analyst Count
  • INUV 2
  • SAVA 3
  • Target Price
  • INUV $2.00
  • SAVA $54.50
  • AVG Volume (30 Days)
  • INUV 148.4K
  • SAVA 857.6K
  • Earning Date
  • INUV 08-07-2025
  • SAVA 08-07-2025
  • Dividend Yield
  • INUV N/A
  • SAVA N/A
  • EPS Growth
  • INUV N/A
  • SAVA N/A
  • EPS
  • INUV N/A
  • SAVA N/A
  • Revenue
  • INUV $93,478,114.00
  • SAVA N/A
  • Revenue This Year
  • INUV $28.36
  • SAVA N/A
  • Revenue Next Year
  • INUV $12.18
  • SAVA N/A
  • P/E Ratio
  • INUV N/A
  • SAVA N/A
  • Revenue Growth
  • INUV 18.20
  • SAVA N/A
  • 52 Week Low
  • INUV $1.90
  • SAVA $1.15
  • 52 Week High
  • INUV $7.90
  • SAVA $42.20
  • Technical
  • Relative Strength Index (RSI)
  • INUV 42.03
  • SAVA 51.81
  • Support Level
  • INUV $3.00
  • SAVA $2.01
  • Resistance Level
  • INUV $3.80
  • SAVA $2.17
  • Average True Range (ATR)
  • INUV 0.34
  • SAVA 0.10
  • MACD
  • INUV -0.05
  • SAVA -0.02
  • Stochastic Oscillator
  • INUV 43.64
  • SAVA 17.31

About INUV Inuvo Inc.

Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Share on Social Networks: